AUS
NZ
UK
CA
USA
IND
Imdex Limited (ASX:IMD), a specialist in drilling optimisation technology and minerals analytics, has reported the expiry of 31,369 performance rights following the failure to meet the conditions required for vesting, rendering them incapable of being fulfilled. This termination took effect on 30 June 2026 and was formally disclosed in a company announcement lodged with the ASX on 1 July 2026. After this adjustment, Imdex's outstanding unquoted performance rights total 18,618,593, while its fully paid ordinary shares remain at 511,841,821. Stakeholders monitoring Imdex's Equity composition and long-term incentive schemes should consider this update as part of regular Capital management disclosures.
Key Points
- Company: Imdex Limited (ASX:IMD)
- 31,369 performance rights (ASX Code: IMDAC) expired on 30 June 2026 due to unmet and impossible-to-satisfy vesting conditions
- No payment was made by Imdex related to the cancellation of these rights
- Remaining unquoted performance rights outstanding: 18,618,593
- Ordinary fully paid shares outstanding remain at 511,841,821 following this change
- Investors should observe forthcoming disclosures for updates on Imdex’s incentive plan and any new performance rights issuances
Details on the Expiry of 31,369 Imdex Performance Rights as of 30 June 2026
On 1 July 2026, Imdex Limited informed the ASX that 31,369 performance rights under the security code IMDAC ceased on 30 June 2026. This occurred because the vesting conditions attached to these rights were not met and could no longer be satisfied. Such expirations are typical within performance rights frameworks, where failure to achieve specified performance targets or conditions within the allotted period results in forfeiture of the rights.
The company confirmed that no consideration was exchanged for the cancellation of these securities, meaning the rights expired without conversion into ordinary shares or any buyback compensation. The Appendix 3H form filed with the ASX provides the official regulatory disclosure for these capital changes, ensuring transparency about shifts in a company’s issued securities.
Implications of Unmet Vesting Conditions on Imdex’s Incentive Structure
Performance rights are commonly used by ASX-listed companies as long-term incentives, granting holders the right to receive ordinary shares at no cost if certain conditions—such as total Shareholder return targets, Earnings Per Share goals, or strategic milestones—are achieved within a defined timeframe. If these conditions are not met, the rights lapse and no shares are issued.
In this instance, Imdex’s announcement did not specify which vesting conditions were unmet nor identify the individuals affected by the lapse. Nonetheless, as of 30 June 2026, these rights are removed from Imdex’s Capital Structure, thereby reducing the total IMDAC performance rights outstanding and marginally decreasing potential future dilution for ordinary shareholders.
Remaining Performance Rights Following the IMDAC Expiry
After the lapse of the 31,369 rights, Imdex holds 18,618,593 unquoted performance rights under the IMDAC class. These represent potential dilution if their vesting conditions are met and shares are issued. It is important to note that these performance rights are unquoted and do not trade on the ASX.
The remaining pool of 18,618,593 rights, compared to the 511,841,821 ordinary shares outstanding, suggests a potential dilution of approximately 3.6% if all rights convert, assuming no other capital changes. This proportion aligns with typical long-term incentive plans among mid-to-large ASX-listed industrial and technology companies. Investors should continue to monitor disclosures related to future grants and vesting outcomes to understand how this pool evolves.
Ordinary Share Count Unaffected at 511,841,821
The expiration of performance rights does not alter the number of fully paid ordinary shares, as conversion only occurs upon satisfaction of vesting conditions. Imdex confirmed its ordinary share count remains at 511,841,821 post-expiry. This figure is used by the ASX in calculating the company’s Market Capitalisation, which is regularly published.
The immediate impact on share price was not evident from public information. Given the relatively small number of lapsed rights versus the large share base, this event is unlikely to materially affect Imdex’s market capitalisation or trading. However, institutional investors and governance analysts closely watch changes in incentive securities as indicators of remuneration effectiveness and alignment with shareholder interests.
No Financial Compensation for Lapsed Performance Rights
Imdex stated that no consideration was paid in relation to the cessation of these 31,369 performance rights. This aligns with standard practice where rights lapse due to unmet conditions, as these are conditional instruments rather than Fully Vested entitlements.
Without any buyback or payment, there is no direct Balance Sheet impact from this event. Financially, the lapse may lead to accounting adjustments reversing previously recognised share-based payment expenses under AASB 2 Share-based Payment, reflecting any unvested accrued expenses related to the lapsed rights. The company did not disclose details of such accounting treatments in its announcement.
Insights from Imdex’s Appendix 3H Filing on Capital Transparency
Filing an Appendix 3H is a mandatory ASX requirement to notify when securities cease to be on issue, detailing the type, quantity, reason, cessation date, and resulting Issued Capital position. Imdex’s timely filing on 1 July 2026, immediately following the 30 June expiry, demonstrates compliance with these obligations.
For investors and analysts, such filings provide valuable information on equity capital management, revealing whether incentive targets are met and how dilution profiles change. Repeated lapses could raise questions about the attainability of performance hurdles, while consistent vesting might indicate strong operational performance. Imdex did not provide further commentary on its incentive plan design or future direction in this update.
Overview of Imdex Limited’s Business and ASX Standing
Imdex Limited is an ASX-listed technology firm serving the global minerals sector. It offers drilling optimisation tools and cloud-connected devices that enhance the speed, accuracy, and efficiency of mining and drilling operations. Its products and services support mineral exploration and mine development across multiple Commodity sectors worldwide.
The company operates in a sector influenced by cyclical Demand linked to commodity prices, exploration activity, and Capital Expenditure by miners of all sizes. Imdex has historically invested in technology innovation and global distribution. As a mid-cap ASX-listed tech and services company, its remuneration framework—including performance rights to incentivise and retain key staff—is a standard governance feature. Investors will be attentive to forthcoming results and disclosures on incentive plan performance.
What Investors Should Watch for in Imdex’s Upcoming Reporting
While the expiry of 31,369 performance rights is a routine matter, it may lead investors to seek more detailed disclosures in Imdex’s next Annual Report or remuneration report. These documents typically provide a detailed breakdown of performance rights granted, vested, lapsed, and outstanding, along with the specific performance metrics involved.
Since the cessation date aligns with the end of Imdex’s financial year on 30 June 2026, the upcoming annual report and remuneration disclosures are expected to shed light on the overall incentive plan results for the year. Stakeholders may also monitor for announcements of new performance rights grants, which would be communicated through an Appendix 2A or similar filings. The release of the full-year financial results and annual report will be key milestones for understanding incentive plan outcomes and any new grant activity.
